Published mark
BeOne Medicines Ltd.
OTC: BEIGF. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80
- SEC CIK
- 0001651308
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- Apr 28, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- John V. OylerSince Apr 28, 2026
- Chair
- Not published
- Independent
- 9 / 1111 directors published
- Published claims
- 373 distinct sources
- Evidence records
- 80 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 8 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
CFO CHANGED
Aaron Rosenberg executive of BeOne Medicines Ltd., effective 2026-04-28.
EffectiveEffective Apr 28, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Financial Officer | Aaron Rosenberg | Apr 2026 | current | Source reportedE3 |
| Senior Vice President, General Counsel and Corporate Secretary | Chan Lee | Apr 2026 | current | Source reportedE4 |
| Co-Founder, Chairman and Chief Executive Officer | John V. Oyler | Apr 2026 | current | Source reportedE5 |
| President, Global Head of Research and Development | Lai Wang | Apr 2026 | current | Source reportedE6 |
| President and Chief Operating Officer | Xiaobin Wu | Apr 2026 | current | Source reportedE7 |
Board of directors
Evidence11 directors published. 9 of 11 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Alessandro Riva | Independent | 2022 | Nominating and Governance | Source reportedE2 |
| Anthony C. Hooper | Independent | 2020 | AuditAudit; Nominating and Governance · ChairNominating and Governance, chair | Source reportedE2 |
| Corazon D. Sanders | Independent | 2020 | Audit | Source reportedE2 |
| John V. Oyler | Not independent | 2010 | None published | Source reportedE2 |
| Margaret Dugan | Independent | 2022 | Compensation, chairCompensation · Chair | Source reportedE2 |
| Michael Goller | Independent | 2015 | Nominating and Governance | Source reportedE2 |
| Olivier Brandicourt | Independent | 2024 | Audit | Source reportedE2 |
| Qingqing Yi | Independent | 2014 | Compensation | Source reportedE2 |
| Ranjeev Krishana | Independent | 2014 | Compensation | Source reportedE2 |
| Shalini Sharp | Independent | 2024 | Audit, chairAudit · Chair; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Xiaodong Wang | Not independent | 2016 | None published | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Shalini Sharp | Shalini Sharp, Anthony C. Hooper, Corazon D. Sanders, Olivier Brandicourt | Not described in the published record |
| Audit · Chair; Nominating and Governance | Not published | Shalini Sharp | Not described in the published record |
| Audit; Nominating and Governance · Chair | Not published | Anthony C. Hooper | Not described in the published record |
| Compensation | Margaret Dugan | Margaret Dugan, Qingqing Yi, Ranjeev Krishana | Not described in the published record |
| Compensation · Chair | Not published | Margaret Dugan | Not described in the published record |
| Nominating and Governance | Anthony C. Hooper | Anthony C. Hooper, Alessandro Riva, Michael Goller, Shalini Sharp | Not described in the published record |
Committee RecordAudit: Chair Shalini Sharp; Members Shalini Sharp (Chair); Anthony C. Hooper; Corazon D. Sanders; Olivier Brandicourt
Committee AppointmentShalini Sharp: chair, Audit
Committee AppointmentAnthony C. Hooper: member, Audit
Committee AppointmentCorazon D. Sanders: member, Audit
Committee AppointmentOlivier Brandicourt: member, Audit
Committee RecordCompensation: Chair Margaret Dugan; Members Margaret Dugan (Chair); Qingqing Yi; Ranjeev Krishana
Committee AppointmentMargaret Dugan: chair, Compensation
Committee AppointmentQingqing Yi: member, Compensation
Committee AppointmentRanjeev Krishana: member, Compensation
Committee RecordNominating and Governance: Chair Anthony C. Hooper; Members Anthony C. Hooper (Chair); Alessandro Riva; Michael Goller; Shalini Sharp
Committee AppointmentAnthony C. Hooper: chair, Nominating and Governance
Committee AppointmentAlessandro Riva: member, Nominating and Governance
Committee AppointmentMichael Goller: member, Nominating and Governance
Committee AppointmentShalini Sharp: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerJohn V. Oyler, Co-Founder, Chairman and Chief Executive Officer, from Apr 28, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingBEIGF (OTC)
Security ListingONC (NASDAQ)
Security Listing06160.HK (HKEX)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameBeOne Medicines Ltd.
Entity StatusPublic listing published
Published FactUS
Published FactHealthcare
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Aaron RosenbergChief Financial Officercompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:17
- Chan LeeSenior Vice President, General Counsel and Corporate Secretarycompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:18
- John V. OylerCo-Founder, Chairman and Chief Executive Officer; Directorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:19, company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:9
- Lai WangPresident, Global Head of Research and Developmentcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:20
- Xiaobin WuPresident and Chief Operating Officercompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:21
- Alessandro RivaDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:6
- Anthony C. HooperDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:7
- Corazon D. SandersDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:8
- Margaret DuganDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:10
- Michael GollerDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:11
- Olivier BrandicourtDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:12
- Qingqing YiDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:13
- Ranjeev KrishanaDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:14
- Shalini SharpDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:15
- Xiaodong WangDirectorcompany:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:16
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 8 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 7 Claims.
- E2sec proxy. Published Apr 7, 2025. Retrieved Apr 24, 2026. Cited by 11 Claims.
- E3sec filing. Published Apr 28, 2026. Retrieved Jul 28, 2026. Cited by 1 Claim.
- E4sec filing. Published Apr 28, 2026. Retrieved Jul 28, 2026. Cited by 1 Claim.
- E5sec filing. Published Apr 28, 2026. Retrieved Jul 28, 2026. Cited by 1 Claim.
- E6sec filing. Published Apr 28, 2026. Retrieved Jul 28, 2026. Cited by 1 Claim.
- E7sec filing. Published Apr 28, 2026. Retrieved Jul 28, 2026. Cited by 1 Claim.
- E8board_seats. board seats. Cited by 14 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- Aaron Rosenberg executive of BeOne Medicines Ltd., effective 2026-04-28.
- Chan Lee executive of BeOne Medicines Ltd., effective 2026-04-28.
- John V. Oyler executive of BeOne Medicines Ltd., effective 2026-04-28.
- Lai Wang executive of BeOne Medicines Ltd., effective 2026-04-28.
- Xiaobin Wu executive of BeOne Medicines Ltd., effective 2026-04-28.
- Olivier Brandicourt seat on BeOne Medicines Ltd., effective 2024-01-01.
- Shalini Sharp seat on BeOne Medicines Ltd., effective 2024-01-01.
- Audit · Chair; Nominating and Governance committee of BeOne Medicines Ltd., effective 2024-01-01.
- Shalini Sharp member of Audit · Chair; Nominating and Governance, effective 2024-01-01.
- Alessandro Riva seat on BeOne Medicines Ltd., effective 2022-01-01.
- Margaret Dugan seat on BeOne Medicines Ltd., effective 2022-01-01.
- Compensation · Chair committee of BeOne Medicines Ltd., effective 2022-01-01.
- Margaret Dugan member of Compensation · Chair, effective 2022-01-01.
- Alessandro Riva member of Nominating and Governance, effective 2022-01-01.
- Anthony C. Hooper seat on BeOne Medicines Ltd., effective 2020-01-01.
- Corazon D. Sanders seat on BeOne Medicines Ltd., effective 2020-01-01.
- Audit; Nominating and Governance · Chair committee of BeOne Medicines Ltd., effective 2020-01-01.
- Anthony C. Hooper member of Audit; Nominating and Governance · Chair, effective 2020-01-01.
- Xiaodong Wang seat on BeOne Medicines Ltd., effective 2016-01-01.
- Michael Goller seat on BeOne Medicines Ltd., effective 2015-01-01.
- Qingqing Yi seat on BeOne Medicines Ltd., effective 2014-01-01.
- Ranjeev Krishana seat on BeOne Medicines Ltd., effective 2014-01-01.
- Qingqing Yi member of Compensation, effective 2014-01-01.
- John V. Oyler seat on BeOne Medicines Ltd., effective 2010-01-01.